07.15.25 -- Radiopharmaceuticals: Navigating FDA Guidance And CMC Considerations

If downstream risks from higher upstream titers hinder your process intensification, PAT and Data Analytics are key. Explore how these tools provide control to mitigate risks and optimize production.

‘Brick dust’ compounds require additional steps if spray drying is to yield a commercially attractive process. Explore three enabling technologies designed to improve drug solubility in organic solvents.

To reduce CO₂ emissions and recycle higher volumes of solvent, drug manufacturers must engineer specialized approaches with flexible technologies that can be adapted.

Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables potent therapies for blood cancers.